JPRN-UMIN000000628
Completed
未知
A study to evaluate the safety and efficacy of ex vivo expanded autologous gamma/delta T cell infusion following zoledronic acid sensitization in patients who received radiotherapy for bone metastases. - A clinical study of combined radiotherapy and gamma/delta T cell therapy for born metastases
niversity of Tokyo, Graduate School of Medicine0 sites10 target enrollmentMarch 5, 2007
ConditionsPatients with bone metastatic cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients with bone metastatic cancer
- Sponsor
- niversity of Tokyo, Graduate School of Medicine
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who have: out\-of\-controlled infections, active autoimmune diseases, serious complications, other cancers, active enteritis, and symptoms of fibroid lung or interstitial pneumonia; who have received continuous systemic steroids; who are pregnant, to be pregnant, or nursing mothers, and whom principle investigator or co\-investigator judged to be inappropriate to participate in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A clinical study for evaluating the safety of excessive consumption of the honey vinegar beveragehypertensionJPRN-UMIN000016586Soiken Inc.40
Active, not recruiting
Phase 1
A Study to Evaluate the Efficacy and Safety of Extraneal Physiological pH Compared with Current Extraneal in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD).End Stage Renal Disease patients receiving continuous ambulatiry peritoneal dialysis (CAPD)MedDRA version: 6.1 Level: LLT Classification code 10014646EUCTR2004-001388-23-DEBaxter R&D Europe SCR120
Active, not recruiting
Phase 1
A Study to Evaluate the Efficacy and Safety of Extraneal Physiological pH Compared with Current Extraneal in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD).End Stage Renal Disease patients receiving continuous ambulatiry peritoneal dialysis (CAPD)MedDRA version: 6.1 Level: LLT Classification code 10014646EUCTR2004-001388-23-DKBaxter R&D Europe SCR120
Active, not recruiting
Phase 1
A Study to Evaluate the Efficacy and Safety of Extraneal Physiological pH Compared with Current Extraneal in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD).End Stage Renal Disease patients receiving continuous ambulatiry peritoneal dialysis (CAPD)MedDRA version: 6.1 Level: LLT Classification code 10014646EUCTR2004-001388-23-GBBaxter R&D Europe SCR120
Active, not recruiting
Not Applicable
A Study to Evaluate the Efficacy and Safety of Extraneal Physiological pH Compared with Current Extraneal in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD).End Stage Renal Disease patients receiving continuous ambulatiry peritoneal dialysis (CAPD)MedDRA version: 6.1Level: LLTClassification code 10014646EUCTR2004-001388-23-SEBaxter R&D Europe SCR120